Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Hannover Medical School

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1965-01-01

Employees: 5K

Market Cap: -

Website: http://www.mh-hannover.de

Clinical Trials

Cutaneous Remote Ischemic Preconditioning in Plastic Surgery

Not Applicable

Completed

Conditions: Ischemic Preconditioning

Interventions: Procedure: remote ischemic preconditioning

First Posted Date: 2010-11-05

Last Posted Date: 2010-11-05

Lead Sponsor: Hannover Medical School

Target Recruit Count: 27

Registration Number: NCT01235286

Locations: 🇩🇪
Medical School Hannover, Hannover, Germany

Off Label Use of Propranolol for Infancy Hemangiomas

Completed

Conditions: Hemangioma

Interventions: Drug: Propranolol

First Posted Date: 2010-09-29

Last Posted Date: 2014-11-11

Lead Sponsor: Hannover Medical School

Target Recruit Count: 72

Registration Number: NCT01211080

Locations: 🇩🇪
Pediatric Surgery, Kinderkrankenhaus Bult, Hannover, Germany
🇩🇪
Pediatric Surgery, Hannover Medical School, Hannover, Lower Saxony, Germany
🇩🇪
Kinderzentrum Klinikum Hildesheim, Hildesheim, Lower Saxony, Germany

TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies

Phase 2

Conditions: Tendinopathy
Epicondylitis

Interventions: Drug: Polidocanol
Device: Focused extracorporeal shock wave therapy
Drug: Topical NO
Behavioral: Painful eccentric training in Achilles tendinopathy
Behavioral: Painful eccentric training for patella tendinopathy on 25° decline board
Behavioral: Painful eccentric training for elbow tendinopathy using Thera-Band Flex-Bar

First Posted Date: 2010-08-20

Last Posted Date: 2010-08-20

Lead Sponsor: Hannover Medical School

Target Recruit Count: 114

Registration Number: NCT01185951

Locations: 🇩🇪
Hannover Medical School, Plastic, Hand and Reconstructive Surgery, Hannover, Germany

Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)

Phase 2

Conditions: Dupuytren Contracture

Interventions: Device: Intervention - ESWT Storz Duolith high energy
Device: CONTROL SHAM-ESWT Storz Duolith [0.01mJ/mm2]

First Posted Date: 2010-08-19

Last Posted Date: 2011-12-02

Lead Sponsor: Hannover Medical School

Target Recruit Count: 60

Registration Number: NCT01184586

Locations: 🇩🇪
Hannover Medical School, Plastic, Hand and Reconstructive Surgery, Hannover, Germany

Efficacy Study of Temsirolimus to Treat Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Biological: Temsirolimus

First Posted Date: 2010-07-30

Last Posted Date: 2013-11-08

Lead Sponsor: Hannover Medical School

Target Recruit Count: 42

Registration Number: NCT01172769

Locations: 🇩🇪
Charitè Berlin Campus Benjamin Franklin Medical Clinic III, Berlin, Germany
🇩🇪
Universitätsklinikum Halle Clinic and Policlinic of internal Medicine IV, Halle, Germany
🇩🇪
Ev. Bethesda- Johanniter Klinikum GmbH Clinic for Heamatology and medical Oncology, Duisburg, Germany

and more 4 locations

A Study in Critically Ill Patients Investigating Tolerability and Efficacy of Low-volume Pharmaconutrition (Intestamin)

Not Applicable

Completed

Conditions: Critical Illness
Adult
Sepsis
Systemic Inflammatory Response Syndrome

Interventions: Dietary Supplement: Fresubin Original
Dietary Supplement: Intestamin plus Fresubin Original

First Posted Date: 2010-07-22

Last Posted Date: 2010-07-22

Lead Sponsor: Hannover Medical School

Target Recruit Count: 58

Registration Number: NCT01167075

Locations: 🇩🇪
Medical School Hannover, Hannover, Niedersachsen, Germany

Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients

Phase 3

Terminated

Conditions: Acute Rejection

Interventions: Drug: Placebo
Drug: Rituximab

First Posted Date: 2010-05-05

Last Posted Date: 2018-08-22

Lead Sponsor: Hannover Medical School

Target Recruit Count: 13

Registration Number: NCT01117662

Locations: 🇩🇪
Universitätsklinikum Münster Innere Medizin / Nephrologie, Münster, Germany
🇩🇪
Nephrologisches Zentrum Niedersachsen 34346 Hannoversch Münden, Hannoversch Münden, Germany
🇩🇪
Universitätsklinikum Jena Klinik für Innere Medizin III, Jena, Germany

and more 11 locations

Vascular Effects of Sitagliptin in Diabetes Mellitus

Phase 4

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Placebo
Other: Control
Drug: Sitagliptin

First Posted Date: 2010-03-31

Last Posted Date: 2010-03-31

Lead Sponsor: Hannover Medical School

Target Recruit Count: 70

Registration Number: NCT01096277

Locations: 🇩🇪
Hannover Medical School, Hannover, Germany

Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections

Phase 4

Completed

Conditions: Wound Infection

Interventions: Drug: Daptomycin
Drug: Cefuroxime

First Posted Date: 2010-03-05

Last Posted Date: 2012-04-17

Lead Sponsor: Hannover Medical School

Target Recruit Count: 650

Registration Number: NCT01080963

Locations: 🇩🇪
Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular surgery, Hannover, Germany

Quetiapine XR in Schizophrenic Patients

Phase 3

Terminated

Conditions: Schizophrenia

Interventions: Drug: Quetiapine XR

First Posted Date: 2010-02-19

Last Posted Date: 2011-11-11

Lead Sponsor: Hannover Medical School

Target Recruit Count: 5

Registration Number: NCT01071135

Locations: 🇩🇪
Hannover Medical School, Hannover, Germany
🇩🇪
Klinikum Wahrendorff, Sehnde, Germany
🇩🇪
Krankenhaus Lübbecke, Lübbecke, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy